abstract |
The invention relates to the use of N-methyl-N - [(1S) -1-phenyl-2 - ((3S) -3-hydroxypyrrolidin-1-yl) ethyl] -2,2-diphenylacetamide (asimadoline, formula VI ) for the manufacture of a medicament for the treatment of Irritable Bowel Syndrome. |